In vivo bone formation by canine mesenchymal stem cells loaded onto HA/TCP scaffolds: Qualitative and quantitative analysis

Yakhteh

Volumn 10, Issue 3, 2008, Pages 205-212

  Eslaminejad, Mohamadreza Baghaban ^a   Jafarian, Mohammad ^b   Khojasteh, Arash ^b   Abbas, Fatemeh Mashhadi ^b   Dehghan, Mohammad Mehdi ^c   Hassanizadeh, Rahele ^b  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Canine mesenchymal stem cells; HA TCP biphasic ceramic; In vivo ectopic bone formation

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN GEL; HYDROXYAPATITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE PROSTHESIS; CELL CULTURE; CELL DIFFERENTIATION; COMPOSITE MATERIAL; CONTROLLED STUDY; EXPERIMENTAL DOG; FIBROBLAST; HISTOLOGY; IMPLANTATION; MASSETER MUSCLE; MESENCHYMAL STEM CELL; MICROSCOPY; NONHUMAN; OSSIFICATION;

EID: 52149106038     PISSN: 15614921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Logeart-Avramoglou D, Anagnostou F, Bizios R, Petite H. Engineering bone: challenges and obstacles: J Cell Mol Med 2005; 9: 72-84
2. Ito K, Yamada Y, Nagaska T, Baba S, Ueda M. Osteogenic potential of injectable tissue-ngineered bone: a comparison among autogenous bone, bone substitute (Bio-Oss), platelet-rich plasma, and issue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mater Res A 2005; 73: 63-72
3. Wiedmann-Al-Ahmad M, Gutwald R, Gellrich NC, Hubner U, Schmelzeisen R. Search for ideal biomaterials to cultivate human osteoblast-like cells for reconstructive surgery. J Mater Sci Mater Med 2005; 16: 57-66
4. Nomura T, Katz L, Powers MP, Saito C. Evaluation of micromechanical elastic properties of potential bone-grafting materials. J Biomed Mater Res part B: Appl Biomater 2004; 73: 29-34
5. Weinand C, Pomerantseva I, Nevilla CM, Gupta R, Weinberg E, Madisch I, et al. Hydrogel-beta-TCP scaffolds and stem cells for tissue engineering bone. Bone 2006; 38: 555-563
6. Vrouwenvelder WCA, de Groot CC, de Groot K: Histological and biochemical evaluation of osteoblasts cultured on bioactive glass, hydroxyapatite, titanium alloy and stainless steel. J Biomed Mater Res 1993; 27:465-75
7. Hench LL. Bioceramics: from concept to clinic. J Am Ceram Soc 1991;74: 1487-510
8. Oonish H. Orthopaedic applications of hydroxyapatite. Biomaterials 1991; 12: 171-178
9. El-Ghannam A. Bone reconstruction: From bioceramics to tissue engineering. Exp Rev Med Devices 2005; 2; 87-101
10. Mao X, Chu CL, Mao Z, Wang JJ. The development and identification of constructing tissue engineered bone by seeding osteoblasts from differentiation rat marrow stromal cells onto three-dimensional porous nano-hydroxyapatite bone matrix in vitro. Tissue Cell 2005; 37: 349-357
11. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997; 6: 125-134
12. Jessop HL, Noble BS, Cryer A. The differentiation of a potential mesenchymal stem cells population within ovine bone marrow. Biochem Soc Trans 1994; 22: 248
13. Eslaminejad MB, Mirzadeh H, Mohamadi Y, Aghbibi N. Bone differentiation of the marrow-derived mesenchymal stem cells using β-tricalcium phosphate/alginate/gelatin hybrid scaffolds. J Tiss Eng Reg Med 2007; in press
14. Eslaminejad MB, Nikmahzar A, Taghiyar L, Nadri S, Massumi M. Murine mesenchymal stem cells isolated by low density primary culture system. Dev Growth Differ 2006; 48, 361-370
15. Cooper LF, Harris CT, Bruder SP, Kowalski R, Kadiyala S: Incipient analysis of mesenchymal stem-cell-derived osteogenesis. J Dent Res 2001; 80: 314-320
16. De Kok IJ, Peter SJ, Archambault M, Vandenbos C, Kadiyala S, Aukhil I, et al. Investigation of allogenic mesenchymal stem cell-based alveolar bone formation: Preliminary findings. Clin Oral Implants Res 2003; 14: 481-489
17. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005; 3: 329-345
18. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, et al. Clinical response to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001; 5: 1227-1231
19. Horwitz EM, Prockop D, Fitzpatrick L, Koo W, Gordon P, Neel M, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med 1999; 3: 309-313
20. Ohgushi H, Miyake J, Tateishi T. Mesenchymal stem cells and bioceramics: strategies to regenerate the skeleton. Novartis Found Symp 2003: 118-127
21. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 2003; 13: 2303-2308
22. Dominci M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international societry for cellular therapy position statement. Cytotherapy 2006; 4: 315-317